- $430.67m
- $372.45m
U.S. STOCKS ON THE MOVE-Coinbase, Rubrik, AeroVironment
U.S. STOCKS ON THE MOVE-Array Technologies, Viking Therapeutics, Winnebago
Forte Biosciences slides on $75 mln equity raise
Forte Biosciences slides on planned equity offering
Forte Biosciences Inc reports results for the quarter ended in June - Earnings Summary
Forte Biosciences Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Camac Fund Says On June 11, Entered Into Settlement Agreement With Forte Biosciences - SEC Filing
Forte Biosciences Inc reports results for the quarter ended in January - Earnings Summary
Forte Biosciences Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Funicular Funds, LP On Oct 28, 2023, Forte Biosciences Filed Vexatious Legal Action Against Jacob Ma-Weaver
Advisory: Alert on ISS recommendation wrongly tagged to ISS A/S withdrawn
Brief: Forte Biosciences Says Files Prospectus Related To Offer,Resale From Time To Time Of Up To 24.9 Mln Shares Of Common Stock By Selling Stockholders
Brief: Camac Partners And Atg Capital Management Sent Letter To Stockholders Of Forte Biosciences
Brief: Camac Fund Reports 4.3% Stake In Forte Biosciences Inc As Of August 16 - SEC Filing
Brief: Forte Biosciences Q2 basic EPS USD -0.42
Brief: Forte Biosciences, Inc. Announces $25 Million Financing And Research And Development Update For FB-102
Brief: Forte Biosciences Inc Announces First Quarter 2023 Results And Provides Business Update
Brief: Jec II Associates, Llc Reports 5.43% Passive Stake In Forte Biosciences As Of March 30- SEC Filing
Brief: Forte Biosciences Inc. Announces Third Quarter 2022 Results, Provides Business Update